Navigation Links
Multiple lipomas within jejunal duplication cyst
Date:5/7/2010

Lipoma of the small intestine is a benign tumor of mesenchymal origin which is mostly found by chance during gastrointestinal investigation. Invaginations account for 2/3 of small bowel occlusion caused by up to 80% of tumors and the lipoma is the most frequent benign tumor that causes invagination in its submucous polypoid and it is in more or less scissile form. However, multiple lipomas within the intestinal duplication canal as a predominant cause of partial intestinal obstruction is an exceptional clinical scenario.

A research article to be published on May 7, 2010 in the World Journal of Gastroenterology addresses this question. The research team from Department of Gastroenterology, Renmin Hospital of Wuhan University, reported a case of a 68-year-old man with a 10-d history of abdominal bloating after meals caused by intussusception due to a small intestine lipomatous lesion located in the jejunal duplication cyst.

Multiple lipomas within jejunal duplication cysts are rare and difficult to diagnose before surgery. This case highlights small intestinal lipoma, though uncommon, should be included in the differential diagnosis of intestinal obstruction and appropriate examination methods should be chosen. Such a case found by double-balloon endoscopy is an example to remind doctors to be vigilant in diagnosing patients with intestinal obstruction and in choosing appropriate examinations.


'/>"/>

Contact: Ye-Ru Wang
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1

Related medicine news :

1. Catching multiple sclerosis before it strikes
2. Statins May Slow Progression of Multiple Sclerosis, New Study Finds
3. Statins may slow progression of multiple sclerosis, new study finds
4. Free CME/CE Lecture and Workshop on Multiple Sclerosis: Boise, ID
5. Clinical benefit of multiple sclerosis drug discovered at Rush University Medical Center
6. Damaka Delivers Advanced Sweeping™ Capability of Live Sessions Across Multiple Devices Over WiFi, 3G and 4G Networks
7. Discovery May Lead to Better Multiple Sclerosis Treatments
8. Kineta Awarded NIH Grant to Complete Preclinical Studies on Type 1 Diabetes / Multiple Sclerosis Drug Candidate
9. Sunwin International & WILD Flavors Receive GRAS Letters of No Objection from FDA Validating Safety of Multiple Sunwin Stevia Extracts
10. 'Miracles For MSA' Proclaims March as Multiple System Atrophy Awareness Month
11. MOVE IT! Join the Movement to End Multiple Sclerosis During MS Awareness Week March 8-14, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... N.J. (PRWEB) , ... June 27, 2016 , ... Quality ... sources, yet in many ways they remain in the eye of the beholder, according ... (EBO), a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
Breaking Medicine Technology: